Literature DB >> 23076632

Reversible loss of N-acetylaspartate after 15-min transient middle cerebral artery occlusion in rat: a longitudinal study with in vivo proton magnetic resonance spectroscopy.

Junchao Qian1, Baojin Qian, Hao Lei.   

Abstract

It is generally accepted that N-acetylaspartate (NAA) can be used a biochemical marker for assessing neuronal viability/integrity after cerebral ischemia. However, this view has recently been questioned based on observations showing that after a photothrombotic permanent ischemia the acute decline of NAA in the infracted regions, where massive neuronal loss persists, is reversible over time. In this study, we measured the longitudinal changes of NAA and total creatine (Cr) in ischemic rat brain after a 15-min transient middle cerebral artery occlusion (MCAO) by in vivo (1)H magnetic resonance spectroscopy. The results showed that the levels of NAA and total Cr in the ischemic lesion decrease significantly at 1 day post-ichemia, followed by spontaneous recovery to the control levels by 2 weeks and remained stable thereafter up to 16 weeks. The normalization of NAA and total Cr levels was associated histologically with persisted neuronal loss up to 90 % in the ischemic core, and accompanied by marked reactive astrocytic responses occurring with a similar time course. The absolute T(2) relaxation time in the ischemic lesion increased during acute phase, and declined afterwards during subacute and chronic phases of 15-min MCAO. The delayed decreases of T(2) in the ischemic lesion might be associated with deposition of paramagnetic species, such as manganese and iron originated from chronic inflammation, vascular degradation and/or hemorrhagic transformation. The results of this study give further support to the hypothesis that the recovery of NAA after cerebral ischemia might have contributions from reactive glia cells, and caution the use of NAA as a specific neuronal marker during the chronic stage of cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076632     DOI: 10.1007/s11064-012-0910-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction.

Authors:  J B Clark
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

2.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

3.  Delayed changes in T1-weighted signal intensity in a rat model of 15-minute transient focal ischemia studied by magnetic resonance imaging/spectroscopy and synchrotron radiation X-ray fluorescence.

Authors:  Xuxia Wang; Junchao Qian; Rui He; Li Wei; Nianqing Liu; Zhiyong Zhang; Yuying Huang; Hao Lei
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

4.  Changes in apparent diffusion coefficients of metabolites in rat brain after middle cerebral artery occlusion measured by proton magnetic resonance spectroscopy.

Authors:  W Dreher; E Busch; D Leibfritz
Journal:  Magn Reson Med       Date:  2001-03       Impact factor: 4.668

5.  Reversible loss of N-acetyl-aspartate in rats subjected to long-term focal cerebral ischemia.

Authors:  Céline Demougeot; Nathalie Bertrand; Anne Prigent-Tessier; Philippe Garnier; Claude Mossiat; Maurice Giroud; Christine Marie; Alain Beley
Journal:  J Cereb Blood Flow Metab       Date:  2003-04       Impact factor: 6.200

6.  Immunohistochemical demonstration of neuron-specific enolase and microtubule-associated protein 2 in reactive astrocytes after injury in the adult forebrain.

Authors:  R C Lin; D F Matesic
Journal:  Neuroscience       Date:  1994-05       Impact factor: 3.590

7.  Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration.

Authors:  Masayuki Fujioka; Toshiaki Taoka; Yoshiyuki Matsuo; Kenichi Mishima; Kumiko Ogoshi; Yoichi Kondo; Masakazu Tsuda; Michihiro Fujiwara; Takao Asano; Toshisuke Sakaki; Akihiro Miyasaki; Darren Park; Bo K Siesjö
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

8.  Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain.

Authors:  Kortaro Tanaka; Shigeru Nogawa; Shigeaki Suzuki; Tomohisa Dembo; Arifumi Kosakai
Journal:  Brain Res       Date:  2003-11-07       Impact factor: 3.252

Review 9.  N-acetylaspartate: a literature review of animal research on brain ischaemia.

Authors:  Céline Demougeot; Christine Marie; Maurice Giroud; Alain Beley
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

10.  Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia.

Authors:  L Passani; S Elkabes; J T Coyle
Journal:  Brain Res       Date:  1998-05-25       Impact factor: 3.252

View more
  4 in total

1.  Hyperbaric oxygen therapy ameliorates local brain metabolism, brain edema and inflammatory response in a blast-induced traumatic brain injury model in rabbits.

Authors:  Yongming Zhang; Yanyan Yang; Hong Tang; Wenjiang Sun; Xiaoxing Xiong; Daniel Smerin; Jiachuan Liu
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

2.  Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study.

Authors:  Hui Zhang; Mingming Huang; Lifeng Gao; Hao Lei
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

3.  The molecular mechanisms affecting N-acetylaspartate homeostasis following experimental graded traumatic brain injury.

Authors:  Valentina Di Pietro; Angela Maria Amorini; Barbara Tavazzi; Roberto Vagnozzi; Ann Logan; Giacomo Lazzarino; Stefano Signoretti; Giuseppe Lazzarino; Antonio Belli
Journal:  Mol Med       Date:  2014-03-24       Impact factor: 6.354

4.  Serial Cerebral Metabolic Changes in Patients With Ischemic Stroke Treated With Autologous Bone Marrow Derived Mononuclear Cells.

Authors:  Muhammad E Haque; Refaat E Gabr; Sarah D George; Seth B Boren; Farhaan S Vahidy; Xu Zhang; Octavio D Arevalo; Susan Alderman; Ponnada A Narayana; Khader M Hasan; Elliott R Friedman; Clark W Sitton; Sean I Savitz
Journal:  Front Neurol       Date:  2019-02-25       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.